This online educational activity has been planned in accordance with the AASLD Financial Disclosure Policy and ACCME Standards for the Integrity and Independence for Accredited Continuing Education by members of the AASLD Transplant Hepatology Board Review Course faculty, the AASLD Maintenance of Certification Committee and the AASLD Governing Board. As an accredited provider, AASLD must collect information from all planners, faculty and others in the planning and control of continuing medical education (CME) activities to disclose all of their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, in ineligible companies. Individuals must disclose financial relationships with ineligible companies regardless of their view of the relevance of the relationship to the education.
The American Association for the Study of Liver Diseases (AASLD) has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair balanced, independent, and free of commercial bias. Conflicts, if any, are resolved through one or more processes. All relevant conflicts pertaining to this activity have been mitigated.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Allie Cao, MD
Nothing to Disclose
Amy Kim, MD
Scientific Consultant: AstraZeneca
Andrew Moon, MD, MPH
Scientific Consultant: Target RWE, IDEOlogy, Eisai
Data Safety Monitoring Board: Intercept
Grant/Research Support: DCN Diagnostics
Anjana Pillai, MD, FAASLD
Scientific Consultant: Replimune, Genentech, Exelixis, Inc., Eisai, Inc., AstraZeneca, Gilead, Boston Scientific
Medical Advisory Board: AstraZeneca, Genentech
Speakers Bureau: Gilead
Charles Kim, MD
Baylis Medical, ACI Humacyte, Kriya Therapeutics
Daniella Sia, PhD
Nothing to Disclose
David Kaplan, MD, FAASLD, FACP, AGAF
Scientific Consultant: Roche Genentech, Sirtex, AstraZeneca, Exelixis
Grant/Research Support: Exact Sciences, AstraZeneca, Glycotest, Inc., Bausch, Gilead
Jeffery Meyer, MD
Intellectual Property Rights: UpToDate, Springer
Julius Chapiro MD, PhD
Scientific Consultant: Guerbet, Bayer, AstraZeneca, Eisai
Kara Wegermann, MD
Scientific Consultant: Focus Medical
Neeraja Kannan, APRN
Nothing to Disclose
Nicole Kim, MD, MPH
Grant/Research Support: Madrigal Pharmaceutical
Nima Kokabi, MD
Scientific Consultant: Boston Scientific, Galvanize Therapeutics, Okami Medical, Sirtex Medical, Terumo Medical
Grant/Research Support: Sirtex Medical
Speaker's Bureau: Sirtex Medical, Okami Medical
Omobonike Oloruntoba-Sanders, MD
Nothing to Disclose
Rachna Shroff, MD
Taiho, QED, Elevar Therapeutics
Sumera Ilyas, MD
Scientific Consultant: AstraZeneca, AstraZeneca Janssen
Veronica Nguyen, MD
Nothing to Disclose
Yuko Kono, MD, PhD, FAASLD
Grant/Research Support: Canon Medical, Bracco Diagnostics
Zachary Goodman, MD, PhD, FAASLD
Nothing to Disclose
STAFF:
Steven Folstein, MFA, M Ed.
Nothing to Disclose
Wendy Risso, MPH
Nothing to Disclose
Sally Cook, CMP, CHCP
Nothing to Disclose